Over the last three years, Congress has sharply increased its legislative activity on defense acquisition reform, with an average of 82 new provisions in this area per year, compared to an average of 47 provisions in the previous decade. “Reform” here often means expanded authority to acquire military goods and services with increased flexibility.
A new report from the Congressional Research Service analyzes and summarizes that recent legislation, which affects contracting, auditing, major defense programs, and many other complicated but important topics. See Acquisition Reform in the FY2016-FY2018 National Defense Authorization Acts (NDAAs), January 4, 2018.
If the National Flood Insurance Program is not reauthorized by Congress prior to January 19, 2018, many of its key provisions will expire. See What Happens If the National Flood Insurance Program (NFIP) Lapses?, CRS Insight, updated January 3, 2018
Other recent reports from the Congressional Research Service include the following.
Department of State, Foreign Operations, and Related Programs: FY2018 Budget and Appropriations, updated January 3, 2018
Cyprus: Reunification Proving Elusive, updated January 2, 2018
Serbia: Background and U.S. Relations, updated January 4, 2018
Membership of the 115th Congress: A Profile, updated January 3, 2018
Clean Air Act Issues in the 115th Congress: In Brief, updated January 3, 2018
Military Service Records and Unit Histories: A Guide to Locating Sources, updated January 2, 2018
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.